J.-T. Lin

3.8k total citations
25 papers, 1.4k citations indexed

About

J.-T. Lin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, J.-T. Lin has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Gastroenterology. Recurrent topics in J.-T. Lin's work include Helicobacter pylori-related gastroenterology studies (9 papers), Gastric Cancer Management and Outcomes (5 papers) and Gastroesophageal reflux and treatments (3 papers). J.-T. Lin is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (9 papers), Gastric Cancer Management and Outcomes (5 papers) and Gastroesophageal reflux and treatments (3 papers). J.-T. Lin collaborates with scholars based in Taiwan and United States. J.-T. Lin's co-authors include Ming‐Shiang Wu, Jin‐Chuan Sheu, Chih‐Hsien Wang, Ding‐Shinn Chen, Jann‐Tay Wang, T.-H. Wang, Yi‐Chia Lee, Chia‐Tung Shun, Chi‐Yang Chang and Han‐Mo Chiu and has published in prestigious journals such as Gut, Biochemical Journal and The Journal of Infectious Diseases.

In The Last Decade

J.-T. Lin

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-T. Lin Taiwan 17 627 379 349 346 318 25 1.4k
Masaaki Kondo Japan 24 434 0.7× 237 0.6× 487 1.4× 318 0.9× 733 2.3× 91 1.6k
Mee Joo South Korea 18 419 0.7× 377 1.0× 242 0.7× 195 0.6× 135 0.4× 80 1.2k
L H Sobin United States 13 646 1.0× 411 1.1× 497 1.4× 492 1.4× 385 1.2× 21 1.7k
Alkwin Wanders Sweden 23 582 0.9× 186 0.5× 265 0.8× 213 0.6× 85 0.3× 77 1.5k
Vedat Göral Türkiye 14 224 0.4× 106 0.3× 196 0.6× 156 0.5× 152 0.5× 41 675
Charu Subramony United States 18 335 0.5× 131 0.3× 202 0.6× 191 0.6× 85 0.3× 60 967
S Dattagupta India 21 378 0.6× 155 0.4× 300 0.9× 221 0.6× 102 0.3× 48 1.2k
Jochen Rudi Germany 16 864 1.4× 260 0.7× 83 0.2× 159 0.5× 53 0.2× 39 1.2k
T. Poralla Germany 19 220 0.4× 129 0.3× 382 1.1× 92 0.3× 372 1.2× 56 973
Mónica García-Buitrago United States 17 270 0.4× 193 0.5× 118 0.3× 287 0.8× 98 0.3× 78 823

Countries citing papers authored by J.-T. Lin

Since Specialization
Citations

This map shows the geographic impact of J.-T. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-T. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-T. Lin more than expected).

Fields of papers citing papers by J.-T. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-T. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-T. Lin. The network helps show where J.-T. Lin may publish in the future.

Co-authorship network of co-authors of J.-T. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of J.-T. Lin. A scholar is included among the top collaborators of J.-T. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-T. Lin. J.-T. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Chenming, et al.. (2020). A spirostanol glycoside from wild yam (Diosccorea villosa) extract and its cytostatic activity on three cancer cells. Journal of Food and Drug Analysis. 15(3). 2 indexed citations
2.
Liou, Jyh‐Ming, Chieh‐Chang Chen, Yi‐Chia Lee, et al.. (2015). Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment ofHelicobacter pyloriinfection. Alimentary Pharmacology & Therapeutics. 43(4). 470–481. 25 indexed citations
3.
Liao, Wei‐Chih, Yu‐Kang Tu, Ming‐Shiang Wu, et al.. (2015). Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ. 349(jan02 3). g7371–g7371. 124 indexed citations
4.
Hsu, Yao‐Chun, Chun‐Ying Wu, Chung‐Yu Chang, et al.. (2014). Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B. Journal of Antimicrobial Chemotherapy. 69(7). 1920–1927. 39 indexed citations
5.
Liou, Jyh‐Ming, Chieh‐Chang Chen, Chung‐Yu Chang, et al.. (2012). Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial. Journal of Antimicrobial Chemotherapy. 68(2). 450–456. 68 indexed citations
6.
Wu, Chun‐Ying, et al.. (2011). Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 60(8). 1038–1042. 53 indexed citations
7.
Liou, Jyh‐Ming, Chieh‐Chang Chen, Mei‐Jyh Chen, et al.. (2011). Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial. Journal of Antimicrobial Chemotherapy. 66(8). 1847–1852. 41 indexed citations
9.
Liao, Wei‐Chih, et al.. (2007). Catastrophic gastrointestinal manifestations of post-transplant lymphoproliferative disorder. Digestive and Liver Disease. 41(3). 238–241. 9 indexed citations
10.
Chiu, Han‐Mo, Chi‐Yang Chang, Yi‐Chia Lee, et al.. (2006). A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia. Gut. 56(3). 373–379. 242 indexed citations
11.
Wu, Ming‐Shiang, et al.. (2005). Proteomic analysis of proteins expressed by Helicobacter pylori under oxidative stress. PROTEOMICS. 5(15). 3895–3901. 41 indexed citations
12.
Chang, Luan‐Yin, et al.. (1999). Anomalous pancreaticobiliary ductal union--an etiologic association of gallbladder cancer and adenomyomatosis.. PubMed. 45(24). 2016–9. 27 indexed citations
13.
Wu, Ming‐Shiang, et al.. (1997). Incomplete pancreas divisum coexistent with anomalous union of pancreaticobiliary duct--report of a Chinese patient.. PubMed. 43(12). 1650–2. 7 indexed citations
14.
Lin, J.-T., et al.. (1995). Endoscopic features of mucosa-associated lymphoid tissue lymphoma of the duodenum. Gastrointestinal Endoscopy. 41(3). 258–261. 22 indexed citations
15.
Lin, J.-T., et al.. (1994). Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori.. PubMed. 93(5). 368–73. 10 indexed citations
16.
Yeh, Yung‐Hsiang, et al.. (1993). Percutaneous Transcystic Cholangioscopy for Combined Treatment of Gallbladder and Bile Duct Stones. Endoscopy. 25(8). 518–522. 4 indexed citations
17.
Battey, James F., Etsuko Wada, J.-T. Lin, et al.. (1992). Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides. Biochemical Journal. 286(2). 641–648. 50 indexed citations
18.
Wang, Jann‐Tay, Jin‐Chuan Sheu, J.-T. Lin, T.-H. Wang, & Ding‐Shinn Chen. (1992). Detection of Replicative Form of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells. The Journal of Infectious Diseases. 166(5). 1167–1169. 168 indexed citations
19.
Coy, D.H., R. T. Jensen, Ning Jiang, et al.. (1992). Systematic development of bombesin/gastrin-releasing peptide antagonists.. PubMed. 133–9. 15 indexed citations
20.
Wang, Jann‐Tay, et al.. (1991). Detection of Hepatitis B Virus DNA by Polymerase Chain Reaction in Plasma of Volunteer Blood Donors Negative for Hepatitis B Surface Antigen. The Journal of Infectious Diseases. 163(2). 397–399. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026